News
25mon MSN
Gene therapy at birth may protect against HIV for years, preclinical study shows promising results
Ardeshir states, "This new hypothesis could help protect newborns in high-risk areas during the most vulnerable period of ...
By Ernie Mundell HealthDay ReporterTHURSDAY, July 31, 2025 (HealthDay News) — There’s potentially exciting news from a trial ...
20h
Live Science on MSNExperimental HIV vaccines show promise in early safety test
Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...
23h
New Scientist on MSNHuman trials point the way towards an mRNA vaccine against HIV
We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...
The Trump administration is appealing the court order to reinstate grants and says it will fight “divisive DEI” in science.
Receiving treatment within the first month of life could protect children for at least three years, a study suggests.
Data from Russia’s defence ministry shows HIV rates among enlisted personnel have skyrocketed since the outbreak of the ...
Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...
The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.
Plasma samples showed an association between suppressed extracellular vesicles and an increased risk for liver cancer.
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results